INVITRO STUDIES OF S-25930 AND S-25932, 2 NEW 4-QUINOLONES

被引：10

作者：

PIDDOCK, LJV

ANDREWS, JM

DIVER, JM

WISE, R

机构：

来源：

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES | 1986年 / 5卷 / 03期

关键词：

D O I：

10.1007/BF02017786

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

收藏

页码：303 / 310

页数：8

相关论文

共 9 条

[1] INVITRO ACTIVITY OF CI-919 (AT-2266), AN ORAL ANTI-PSEUDONOMAL COMPOUND
CHARTRAND, SA
SCRIBNER, RK
WEBER, AH
WELCH, DF
MARKS, MI
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1983, 23 (05) : 658 - 663
[2] NALIDIXIC-ACID - ANTIBACTERIAL PARADOX
CRUMPLIN, GC
SMITH, JT
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1975, 8 (03) : 251 - 261
[3] THE INVITRO ACTIVITIES OF ENOXACIN AND OFLOXACIN COMPARED WITH THAT OF CIPROFLOXACIN
KING, A
SHANNON, K
PHILLIPS, I
[J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1985, 15 (05) : 551 - 558
[4] INVITRO ACTIVITY OF NORFLOXACIN, A QUINOLINECARBOXYLIC ACID, COMPARED WITH THAT OF BETA-LACTAMS, AMINOGLYCOSIDES, AND TRIMETHOPRIM
NEU, HC
LABTHAVIKUL, P
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1982, 22 (01) : 23 - 27
[5] RATCLIFFE NT, 1983, J PHARM PHARMACOL, V35, P61
[6] INVITRO STUDIES WITH CIPROFLOXACIN, A NEW 4-QUINOLONE COMPOUND
REEVES, DS
BYWATER, MJ
HOLT, HA
WHITE, LO
[J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1984, 13 (04) : 333 - 346
[7] Richmond M H, 1973, Adv Microb Physiol, V9, P31, DOI 10.1016/S0065-2911(08)60376-8
[8] INVITRO ACTIVITY OF BAY-09867, A NEW QUINOLINE DERIVATIVE, COMPARED WITH THOSE OF OTHER ANTI-MICROBIAL AGENTS
WISE, R
ANDREWS, JM
EDWARDS, LJ
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1983, 23 (04) : 559 - 564
[9] INVITRO ACTIVITY OF ENOXACIN (CI-919), A NEW QUINOLINE DERIVATIVE, COMPARED WITH THAT OF OTHER ANTIMICROBIAL AGENTS
WISE, R
ANDREWS, JM
DANKS, G
[J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1984, 13 (03) : 237 - 244